Latest news and insights on the pharmaceutical industry | Indian Pharma Post | Page 17

Results For "liver"

2586 News Found

Parse Biosciences unveils integrated immune profiling in Trailmaker Platform
News | January 28, 2026

Parse Biosciences unveils integrated immune profiling in Trailmaker Platform

The new functionality complements Parse’s existing Evercode immune products


Granules India consolidated Q3 FY26 PAT rises to Rs. 150.21 Cr
News | January 25, 2026

Granules India consolidated Q3 FY26 PAT rises to Rs. 150.21 Cr

Granules India has reported total income of Rs. 1,384.29 crore during the period ended December 31, 2025


Amway India launches ‘Beyond Biotin’ Nutrilite Biotin C Plus to support skin, hair, nail health
News | January 24, 2026

Amway India launches ‘Beyond Biotin’ Nutrilite Biotin C Plus to support skin, hair, nail health

The product delivers 100 percent of the Recommended Dietary Allowance (RDA) of three essential nutrients—Biotin, Vitamin C and Zinc


Rising demand for obesity drugs hits employer healthcare budgets, says Howden Report
News | January 24, 2026

Rising demand for obesity drugs hits employer healthcare budgets, says Howden Report

The research shows 93% of global companies now cover weight-management drugs in their health insurance plans


Akums bags key EU GMP certifications for 2 Haridwar plants
News | January 24, 2026

Akums bags key EU GMP certifications for 2 Haridwar plants

Plant 1 continues to serve as a core manufacturing hub for oral solid dosage forms


Novo Medi Sciences unveils India’s next-generation varicella vaccine NEXIPOX PLUS
R&D | January 24, 2026

Novo Medi Sciences unveils India’s next-generation varicella vaccine NEXIPOX PLUS

This innovation enhances viral stability, preserves potency, and reduces allergic reactions and antigen crystallisation-related issues


Functional Gut Clinic launches UK’s first boutique GI clinical trials division
Clinical Trials | January 23, 2026

Functional Gut Clinic launches UK’s first boutique GI clinical trials division

Gastrointestinal conditions affect millions across the UK, yet research in the field has often been fragmented, slow, or under-resourced


Brenig Therapeutics launches first-in-human trial of novel neurodegenerative therapy
News | January 21, 2026

Brenig Therapeutics launches first-in-human trial of novel neurodegenerative therapy

The Phase 1 single and multiple ascending dose study is set to begin dosing in early Q1 2026